1. Home
  2. AVDL vs VTS Comparison

AVDL vs VTS Comparison

Compare AVDL & VTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • VTS
  • Stock Information
  • Founded
  • AVDL 2015
  • VTS 2014
  • Country
  • AVDL Ireland
  • VTS United States
  • Employees
  • AVDL N/A
  • VTS N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • VTS Oil & Gas Production
  • Sector
  • AVDL Health Care
  • VTS Energy
  • Exchange
  • AVDL Nasdaq
  • VTS Nasdaq
  • Market Cap
  • AVDL 900.2M
  • VTS 824.8M
  • IPO Year
  • AVDL 1996
  • VTS N/A
  • Fundamental
  • Price
  • AVDL $9.54
  • VTS $23.76
  • Analyst Decision
  • AVDL Strong Buy
  • VTS Strong Buy
  • Analyst Count
  • AVDL 6
  • VTS 4
  • Target Price
  • AVDL $18.17
  • VTS $30.25
  • AVG Volume (30 Days)
  • AVDL 1.6M
  • VTS 409.7K
  • Earning Date
  • AVDL 08-07-2025
  • VTS 08-04-2025
  • Dividend Yield
  • AVDL N/A
  • VTS 9.48%
  • EPS Growth
  • AVDL N/A
  • VTS N/A
  • EPS
  • AVDL N/A
  • VTS 0.76
  • Revenue
  • AVDL $194,450,000.00
  • VTS $225,502,000.00
  • Revenue This Year
  • AVDL $56.88
  • VTS $21.47
  • Revenue Next Year
  • AVDL $29.81
  • VTS N/A
  • P/E Ratio
  • AVDL N/A
  • VTS $31.27
  • Revenue Growth
  • AVDL 252.64
  • VTS 4.90
  • 52 Week Low
  • AVDL $6.38
  • VTS $18.90
  • 52 Week High
  • AVDL $17.30
  • VTS $28.41
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 56.42
  • VTS 58.83
  • Support Level
  • AVDL $8.74
  • VTS $23.06
  • Resistance Level
  • AVDL $9.56
  • VTS $24.00
  • Average True Range (ATR)
  • AVDL 0.39
  • VTS 0.68
  • MACD
  • AVDL 0.04
  • VTS 0.05
  • Stochastic Oscillator
  • AVDL 81.92
  • VTS 88.89

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About VTS Vitesse Energy Inc.

Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.

Share on Social Networks: